LENG9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.52775578246656E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87761999999037E-05 |
Normal-vs-Stage2 |
3.604500E-02 |
Normal-vs-Stage3 |
9.50139966704455E-10 |
Normal-vs-Stage4 |
1.15559783964159E-11 |
Stage1-vs-Stage2 |
3.076800E-01 |
Stage1-vs-Stage3 |
2.102000E-01 |
Stage1-vs-Stage4 |
7.923300E-03 |
Stage2-vs-Stage3 |
5.170000E-01 |
Stage2-vs-Stage4 |
8.812600E-01 |
Stage3-vs-Stage4 |
1.168640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.20209953102801E-10 |
Normal-vs-AfricanAmerican |
1.91329999621459E-08 |
Normal-vs-Asian |
9.851900E-02 |
Caucasian-vs-AfricanAmerican |
4.878000E-01 |
Caucasian-vs-Asian |
5.683800E-01 |
AfricanAmerican-vs-Asian |
6.237000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.48129977570488E-10 |
Normal-vs-Female |
1.7510000005494E-08 |
Male-vs-Female |
1.267990E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.980830E-03 |
Normal-vs-Age(41-60Yrs) |
1.17669999999404E-06 |
Normal-vs-Age(61-80Yrs) |
2.04979999640642E-08 |
Normal-vs-Age(81-100Yrs) |
2.423300E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.511800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.919800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.978400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.683600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.281600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.520800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.109600E-02 |
Normal-vs-Grade 2 |
2.390200E-04 |
Normal-vs-Grade 3 |
1.86606285978996E-12 |
Normal-vs-Grade 4 |
1.66719971161911E-10 |
Grade 1-vs-Grade 2 |
5.876400E-02 |
Grade 1-vs-Grade 3 |
5.017600E-03 |
Grade 1-vs-Grade 4 |
1.99117999999388E-05 |
Grade 2-vs-Grade 3 |
9.236400E-01 |
Grade 2-vs-Grade 4 |
6.294000E-02 |
Grade 3-vs-Grade 4 |
7.424800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.42179999999648E-05 |
Normal-vs-ccB subtype |
2.5436319717187E-12 |
ccA subtype-vs-ccB subtype |
2.81540000002245E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.16139999994935E-06 |
Normal-vs-N1 |
6.416800E-03 |
N0-vs-N1 |
8.110400E-01 |
|
|